天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Solifenacin Related CoMpound 2 Succinate

Solifenacin Related CoMpound 2 Succinate

Solifenacin Related CoMpound 2 Succinate Suppliers list
Company Name: CR Corporation Limited
Tel: +8613062833949
Email: fred.wen@crcorporation.cn
Products Intro: Product Name:Solifenacin EP impurity F
CAS:1262506-09-1
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Solifenacin Related Compound 2 Succinate
CAS:1262506-09-1
Purity:> 95% Remarks:A impurity of Solifenacin. Solifenacin is a muscarinic M3 receptor antagoinst for treating contracti
Company Name: BOC Sciences  
Tel: 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Solifenacin Related Compound 2 Succinate
CAS:1262506-09-1
Purity:>95%
Company Name: Roark Standards  
Tel: 0755-83552066 15986688328
Email: service@roarkstandards.com
Products Intro: Product Name:(1R,3S)-Solifenacin Succinate
CAS:1262506-09-1
Purity:98% HPLC Package:10MG;25MG;50MG;100MG
Company Name: Shenzhen SUNGENING Bio-Medical Co., Ltd.  
Tel: 0755-28967200 13631290199
Email: wxf@sungening.com
Products Intro: Product Name:(R,S)-Solifenacin Succinate
CAS:1262506-09-1
Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
Solifenacin Related CoMpound 2 Succinate Basic information
Product Name:Solifenacin Related CoMpound 2 Succinate
Synonyms:Solifenacin Related CoMpound 2 Succinate;Solifenacin EP Impurity F Succinate;(R)-(1R,3S,4R)-quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;(3S)-1-azabicyclo[2.2.2]octan-3-yl(1R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate;(R,S)-Solifenacin Succinate;(R)-(S)-quinuclidin-3-yl;Solifenacin Succinate - Impurity F (Succinate Salt)Q: What is Solifenacin Succinate - Impurity F (Succinate Salt) Q: What is the CAS Number of Solifenacin Succinate - Impurity F (Succinate Salt);(3S)-1-Azabicyclo[2.2.2]oct-3-yl (1R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate Succinate Salt
CAS:1262506-09-1
MF:C27H32N2O6
MW:480.56
EINECS:
Product Categories:
Mol File:1262506-09-1.mol
Solifenacin Related CoMpound 2 Succinate Structure
Solifenacin Related CoMpound 2 Succinate Chemical Properties
solubility Chloroform (Slightly), DMSO (Slightly), Ethanol (Slightly, Heated), Methanol (Slightly)
form Solid
color White to Yellow
Stability:Hygroscopic
Safety Information
MSDS Information
Solifenacin Related CoMpound 2 Succinate Usage And Synthesis
Uses(R,S)-Solifenacin Succinate is an impurity of Solifenacin Succinate (S676701), a muscarinic M3 receptor antagoinst and used in treatment of urinary incontinence.
Solifenacin Related CoMpound 2 Succinate Preparation Products And Raw materials
Tag:Solifenacin Related CoMpound 2 Succinate(1262506-09-1) Related Product Information
Emulsified silicone oil Solifenacin Related Compound 19 Solifenacin Related Compound 3 Succinate (R)-(-)-3-Quinuclidinol Solifenacin Related CoMpound 4 Succinate Solifenacin Impurity 1 HCl Solifenacin N-Oxide 1-Phenyl-3,4-dihydroisoquinoline Solifenacin Related Compound 18 Solifenacin-d5 Hydrochloride Solifenacin IMpurity 1-Phenyl-1,2,3,4-tetrahydro-isoquinoline (1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline 3-Quinuclidinone hydrochloride 3-QUINUCLIDINONE Solifenacin Related Compound 29 Solifenacin Related Compound 25 Solifenacin Impurity 2

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.